Skip to Content

93 5513 93 5513 (Carbamazepine Extended-Release 200 mg)

Pill with imprint 93 5513 93 5513 is Green / Gray, Capsule-shape and has been identified as Carbamazepine Extended-Release 200 mg. It is supplied by Teva Pharmaceuticals USA Inc..

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 5513 93 5513

Carbamazepine Extended-Release

93 5513 93 5513
200 mg
Green / Gray
Prescription only
Drug Class
Dibenzazepine anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.